Electromobility Shift Assay Reveals Evidence in Favor of Allele-Specific Binding of RUNX1 to the 5′ Hypersensitive Site 4-Locus Control Region

References

• Cooper N, Hart D, Bates I, Cotter FE. The importance of developing world haematology. Br J Haematol. 2011;154(6):667
   PubMed Web of Science ®Google Scholar
• Rund D. Thalassemia 2016: modern medicine battles an ancient disease. Am J Hematol. 2015;91(1):15–21
   Web of Science ®Google Scholar
• Sankaran VG, Weiss MJ. Anemia: progress in molecular mechanisms and therapies. Nat Med. 2015;21(3):221–230
   PubMed Web of Science ®Google Scholar
• Ngo DA, Steinberg MH. Genomic approaches to identifying targets for treating β hemoglobinopathies. BMC Med Genomics. 2015;8:44
   PubMed Web of Science ®Google Scholar
• Stamatoyannopoulos G, Grosveld F. Hemoglobin switching. In: Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H, Eds. The Molecular Basis of Blood Disease, 3rd ed. Philadelphia, PA, USA: W.B. Saunders, 2001:135–182
   Google Scholar
• Patrinos GP, de Krom M, de Boer E, et al Multiple interactions between regulatory regions are required to stabilize an active chromatin hub. Genes Dev. 2004;18(12):1495–1509
   PubMed Web of Science ®Google Scholar
• Kim A, Dean A. Chromatin loop formation in the β-globin locus and its role in globin gene transcription. Mol Cells. 2012;34(1):1–5
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. Commentary on “The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the β globin locus control region, including the palindromic site at 5′ HS4.” by M. Neishabury et al. Blood Cells Mol Dis. 2012;48(1):6
   PubMed Web of Science ®Google Scholar
• Neishabury M, Zamani S, Azarkeivan A, et al The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the β globin locus control region, including the palindromic site at 5′HS4. Blood Cells Mol Dis. 2012;48(1):1–5
   PubMed Web of Science ®Google Scholar
• Kukreti R, B-Rao Das SK, et al Study of the single nucleotide polymorphism (SNP) at the palindromic sequence of hypersensitive site (HS)4 of the human β-globin locus control region (LCR) in Indian population. Am J Hematol. 2002;69(1):77–79
   PubMed Web of Science ®Google Scholar
• Kukreti R, Dash D, E VK, et al Spectrum of β-thalassemia mutations and their association with allelic sequence polymorphisms at the β-globin gene cluster in an Eastern Indian population. Am J Hematol. 2002;70(4):269–277
   PubMed Web of Science ®Google Scholar
• Kaushik M, Kukreti R, Grover D, et al Hairpin-duplex equilibrium reflected in the A→B transition in an undecamer quasi-palindrome present in the locus control region of the human β-globin gene cluster. Nucleic Acids Res. 2003;31(23):6904–6915
   PubMed Web of Science ®Google Scholar
• Kaushik M, Kukreti S. Structural polymorphism exhibited by a quasipalindrome present in the locus control region (LCR) of the human β-globin gene cluster. Nucleic Acids Res. 2006;34(12):3511–3522
   PubMed Web of Science ®Google Scholar
• Kukreti S, Kaur H, Kaushik M, et al Structural polymorphism at LCR and its role in β-globin gene regulation. Biochimie. 2010;92(9):1199–1206
   PubMed Web of Science ®Google Scholar
• Nuinoon M, Makarasara W, Mushiroda T, et al A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/Hemoglobin E. Hum Genet. 2010;127(3):303–314
   PubMed Web of Science ®Google Scholar
• Bean CJ, Boulet SL, Yang G, et al Acute chest syndrome is associated with single nucleotide polymorphism-defined β-globin cluster haplotype in children with sickle cell anaemia. Br J Haematol. 2013;163(2):268–276
   PubMed Web of Science ®Google Scholar
• Neishabury M, Azarkeivan A, Oberkanins C, et al Molecular mechanisms underlying thalassemia intermedia in Iran. Genet Test. 2008;12(4):549–556
   PubMedGoogle Scholar
• Rund D, Fucharoen S. Genetic modifiers in hemoglobinopathies. Curr Mol Med. 2008;8(7):600–608
   PubMed Web of Science ®Google Scholar
• Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379(9813):373–383
   PubMed Web of Science ®Google Scholar
• Thein SL, Menzel S, Lathrop M, Garner C. Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet. 2009;18(R2):R216–R223
   PubMed Web of Science ®Google Scholar
• Cao A, Moi P, Galanello R. Recent advances in β-thalassemias. Pediatr Rep. 2011;3(2):e17
   PubMedGoogle Scholar
• Levantini E, Lee S, Radomska HS, et al RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element. EMBO J. 2011;30(19):4059–4070
   PubMed Web of Science ®Google Scholar
• Imperato MR, Cauchy P, Obier N, Bonifer C. The RUNX1-PU.1 axis in the control of hematopoiesis. Int J Hematol. 2015;101(4):319–329
   PubMed Web of Science ®Google Scholar
• Kent WJ, Sugnet CW, Furey TS, et al The human genome browser at UCSC. Genome Res. 2002;12(6):996–1006
   PubMed Web of Science ®Google Scholar
• Feng D, Kan YW. The binding of the ubiquitous transcription factor Sp1 at the locus control region represses the expression of β-like globin genes. Proc Natl Acad Sci U.S.A. 2005;102(28):9896–9900
   PubMed Web of Science ®Google Scholar
• Sandelin A, Wasserman WW, Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 2004;32:W249–W252
   PubMed Web of Science ®Google Scholar
• Wingender E, Chen X, Hehl R, et al TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 2000;28(1):316–319
   PubMed Web of Science ®Google Scholar
• Wingender E. The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform. 2008;9(4):326–332
   PubMed Web of Science ®Google Scholar
• Kaur G, Jalagadugula G, Mao G, Rao AK. RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): Studies in human RUNX1 haplodeficiency. Blood. 2010;115(15):3128–3135
   PubMed Web of Science ®Google Scholar
• Kuvardina ON, Herglotz J, Kolodziej S, et al RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation. Blood. 2015;125(23):3570–3579
   PubMed Web of Science ®Google Scholar
• Staber PB, Zhang P, Ye M, et al The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. Blood. 2014;124(15):2391–2399
   PubMed Web of Science ®Google Scholar
• Carter D, Chakalova L, Osborne CS, et al Long-range chromatin regulatory interactions in vivo. Nat Genet. 2002;32(4):623–626
   PubMed Web of Science ®Google Scholar
• Tolhuis B, Palstra RJ, Splinter E, et al Looping and interaction between hypersensitive sites in the active β-globin locus. Mol Cell. 2002;10(6):1453–1465
   PubMed Web of Science ®Google Scholar
• Hellman LM, Fried MG. Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. Nat Protoc. 2007;2(8):1849–1861
   PubMed Web of Science ®Google Scholar
• Lorian V. Differences between in vitro and in vivo studies. Antimicrob Agents Chemother. 1988;32(10):1600–1601
   PubMed Web of Science ®Google Scholar